Conversely, dulaglutide exhibited an increasing trend in median onset time as age progressed.
← all excerpts
Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database.
1
—
—